PAM
CRMD icon

Panagora Asset Management’s CorMedix CRMD Stock Holding History

Panagora Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,048
Closed -$12K – 2829
2020
Q3 		$12K Hold
2,048
– – ﹤0.01% 2294
2020
Q2 		$13K Hold
2,048
– – ﹤0.01% 2208
2020
Q1 		$7K Sell
2,048
-4,811
-70% -$27.2K ﹤0.01% 2199
2019
Q4 		$50K Buy
+6,859
New +$41.9K ﹤0.01% 1917

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Panagora Asset Management's CRMD Position: Q4 2020 in Review

Panagora Asset Management sold out of CorMedix (CRMD) in Q4 2020, closing a stake of 2,048 shares — an estimated $12K sold.

Panagora Asset Management first reported a position in CRMD in Q4 2019 and held it in 4 quarters. The position peaked at $50K in Q4 2019. 75 funds tracked by Wall St. Rank hold CRMD as of Q4 2020.

  • Panagora Asset Management reported no remaining CorMedix position as of Q4 2020 after selling out during the quarter.
  • Panagora Asset Management sold 2,048 CorMedix shares in Q4 2020, an estimated $12K.
  • Panagora Asset Management first reported a position in CorMedix in Q4 2019 and held it in 4 quarters.
  • Panagora Asset Management's CorMedix position peaked at $50K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held CorMedix as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.